drugset / Trial / NCT00983151

Study to Evaluate Efficacy and Safety in Males Subjects With Premature Ejaculation

NCT00983151

Phase 3 Terminated 1050 enrolled Bausch Health Americas, Inc.
RandomizedParallel-groupDouble-blind

Summary

The purpose of this clinical trial is to test an experimental drug therapy called Tramadol Hydrochloride (HCl) Orally Disintegrating Tablets (ODT) ("Tramadol HCl ODT" or the "study drug"). The subject and his partner are being asked to be in this clinical trial because they have a condition called premature ejaculation.

Timeline

Start
2009-08
Primary completion
2010-09
Completion
2010-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Tramadol Other / unclassified 62 mg Oral
Subject Tramadol Other / unclassified 89 mg Oral

Indications